Business

CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage

The CDC’s move to increase availability of Beyfortus, a monoclonal antibody from Sanofi and AstraZeneca, comes as RSV cases rise in some parts of the country.

Previous post UAW members ratify new contract with Chrysler owner Stellantis
Next post : Tesla’s stock bounces into positive territory, to erase losses suffered after CEO Elon Musk’s controversial comments

More Stories